The OTIPRIO brand, founded in 2015 (United States), from
3 sister brands
and 2214 competing brands.
OTIPRIO is owned by Otonomy, listed on the stock exchange of Etats-Unis
OTIPRIO is part of the Biotechnology activity sector.
Only companies with a strong brand or unique know-how benefit from this ability to set their prices without impacting demand and thus preserve their margins.